Simbrinza 10 mg/mL + 2 mg/mL Eye drops, suspension
PDF Leaflet Revision Date: 06 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Lowering elevated intraocular pressure in glaucoma or ocular hypertension.
Dosage (summary)
One drop in affected eye(s) twice daily for adults.
Special Populations
- Hepatic impairment
- Severe renal impairment
- Elderly
Pregnancy & Breastfeeding
Not recommended in pregnancy or breastfeeding.
Key Drug Interactions
- Monoamine oxidase inhibitors
- Tricyclic antidepressants
- CNS depressants
Contraindications
- Hypersensitivity to active substances
- Severe renal impairment
- Neonates and infants under 2 years
Common side effects
- Ocular hyperaemia
- Dysgeusia
- Ocular allergic reactions
Counselling Points
- Do not touch dropper tip to avoid contamination.
- Remove contact lenses before use.
- Monitor for signs of allergic reactions.
Serious warnings
- Serious hypersensitivity reactions possible.
- Caution in patients with cardiovascular disease.
Important Disclaimer
The Simbrinza 10 mg/mL + 2 mg/mL Eye drops, suspension professional information leaflet below is the property of Novartis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
